bpc-157 clinical trials registered 10 mg BPC-157 - 5 MG

Safety Considerations Safety remains a paramount concern when evaluating new therapeutic agents

A small interstitial cystitis pilot study reported improvement in 12 women after BPC-157 injections around bladder inflammation, but that was also early, small, and not enough to settle efficacy (PubMed)

However, additional efforts are necessary to establish comparability between SAXS and traditional methods used for drug product characterization

Strong genetic predisposition to cancer, especially aggressive or early-onset cancers, elevates baseline risk

Exendin-4 attenuates pain-induced cognitive impairment by alleviating hippocampal neuroinflammation in a rat model of spinal nerve ligation